BioResearch
Regulatory T Cells Hamper Fight Against Cancer
Researchers have found that while some cancer patients develop specific cytolytic lymphocytes that should destroy their tumors, these cells are prevented from acting due to a chemical signal transmitted by another set of immune cells called regulatory T cells. More...23 Sep 2002
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Manual Pipetting Aid
Pipette Controllers macro
All-in-One Molecular System
AIO M160
In Other News
Insights into the Anticancer Action of Sulforaphane
Short Oligonucleotides Used in New Antisense Technology
Alliance to Develop Drugs to Treat Strokes
Protein Identified that Mediates T-Cell Activation
Protein Helps Wire Up Circuitry Controlling Muscle
Sleep Apnea Sufferers Produce Less Testosterone
Atherogenic Role Seen for C-Reactive Protein
Worldwide Regulatory Services for Medical Industry
Notch1 Expression Level Varies in HPV
Researchers Engineer Parts of Rabbit Penises
Dramatic Genetic Consequences of Single Amino Acid Change
Artery-Blocking Cells Circulate in the Blood
New System for Proteomics Research
Protein Identified that Controls Synapse Formation
Telomerase Inhibitor May Treat Many Types of Cancer
Normal Cells Sequester Telomerase But Cancer Cells Do Not
Alliance to Develop New Technologies in Proteomics
Vaccine Developed Against Bioterrorism Toxin
Scientists Develop a Way to Make Drugs Safer
Microarray with Rat Biochip with 10,000 Genes
Outwitting Cancer's Defense Mechanism
Tumor Proliferation Gene Identified
Lipid Buildup in Motor Neurons May Trigger ALS
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.